The cone of silence surrounding preclinical activities doesn't help us, at least not short term. Rusty longs reading publications out of Newcastle all have a fair idea as to what has transpired... but this doesn't entice new investors.
If you can't talk about the preclinical value add, you've got to be delivering clinically. Right now we've neither, and as such, RAC still has a buyers problem.
The cone of silence surrounding preclinical activities doesn't...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.080(6.30%) |
Mkt cap ! $234.5M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.45 | $1.35 | $317.3K | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25695 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 4775 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |